Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation

OBJECTIVE: Currently, there are limited comparative data concerning long-term major clinical outcomes following the angiotensin-converting-enzyme inhibitors (ACEIs) and angiotensin II type 1 (AT1) receptor blockers (ARBs) therapy in patients with acute myocardial infarction (AMI) with dyslipidemia a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong Hoon, Her, Ae-Young, Jeong, Myung Ho, Kim, Byeong-Keuk, Hong, Sung-Jin, Kim, Seunghwan, Ahn, Chul-Min, Kim, Jung-Sun, Ko, Young-Guk, Choi, Donghoon, Hong, Myeong-Ki, Jang, Yangsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040876/
https://www.ncbi.nlm.nih.gov/pubmed/32011324
http://dx.doi.org/10.14744/AnatolJCardiol.2019.60374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040876/
https://www.ncbi.nlm.nih.gov/pubmed/32011324
http://dx.doi.org/10.14744/AnatolJCardiol.2019.60374

Ejemplares similares